| P2093 | author name string | Kalpana Ghoshal | |
| | Samson T Jacob | |
| | Sarmila Majumder | |
| | Saradhadevi Varadharaj | |
| | Arthur H M Burghes | |
| | Umrao Monani | |
| P2860 | cites work | A novel function for SMN, the spinal muscular atrophy disease gene product, in pre-mRNA splicing | Q22008514 |
| | Transcription factor ATF cDNA clones: an extensive family of leucine zipper proteins able to selectively form DNA-binding heterodimers | Q24302559 |
| | The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins | Q24316085 |
| | The SMN-SIP1 complex has an essential role in spliceosomal snRNP biogenesis | Q24316121 |
| | A novel nuclear structure containing the survival of motor neurons protein | Q24324247 |
| | Intragenic telSMN mutations: frequency, distribution, evidence of a founder effect, and modification of the spinal muscular atrophy phenotype by cenSMN copy number. | Q24539804 |
| | Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 |
| | Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei | Q27860728 |
| | Essential role for the tudor domain of SMN in spliceosomal U snRNP assembly: implications for spinal muscular atrophy | Q28137718 |
| | An in vivo reporter system for measuring increased inclusion of exon 7 in SMN2 mRNA: potential therapy of SMA | Q28204816 |
| | Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients | Q28209134 |
| | Specific interaction of Smn, the spinal muscular atrophy determining gene product, with hnRNP-R and gry-rbp/hnRNP-Q: a role for Smn in RNA processing in motor axons? | Q28214361 |
| | Tissue-specific in vitro transcription from the mouse albumin promoter | Q28304622 |
| | SREBP cleavage-activating protein (SCAP) is required for increased lipid synthesis in liver induced by cholesterol deprivation and insulin elevation | Q28365331 |
| | Expression of the survival of motor neuron (SMN) gene in primary neurons and increase in SMN levels by activation of the N-methyl-D-aspartate glutamate receptor | Q28565334 |
| | Identification and characterization of a spinal muscular atrophy-determining gene | Q29547495 |
| | A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy | Q29617367 |
| | Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133 | Q29617856 |
| | CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals | Q29620470 |
| | Genetic studies of acute infantile spinal muscular atrophy (SMA type I). An analysis of sex ratios, segregation ratios, and sex influence | Q33588373 |
| | A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. | Q33864982 |
| | Treatment of spinal muscular atrophy by sodium butyrate | Q33933841 |
| | Animal models of spinal muscular atrophy | Q34045913 |
| | A frame–shift deletion in the survival motor neuron gene in Spanish spinal muscular atrophy patients | Q34297206 |
| | Quantitative analysis of survival motor neuron copies: identification of subtle SMN1 mutations in patients with spinal muscular atrophy, genotype-phenotype correlation, and implications for genetic counseling | Q34389556 |
| | An 11 base pair duplication in exon 6 of the SMN gene produces a type I spinal muscular atrophy (SMA) phenotype: further evidence for SMN as the primary SMA-determining gene. | Q34407787 |
| | Missense mutation clustering in the survival motor neuron gene: a role for a conserved tyrosine and glycine rich region of the protein in RNA metabolism? | Q34425819 |
| | Macromolecular complexes: SMN — the master assembler | Q34429700 |
| | The survival motor neuron protein in spinal muscular atrophy | Q34435656 |
| | In vivo footprinting of a muscle specific enhancer by ligation mediated PCR. | Q34550385 |
| | Bifunctional antisense oligonucleotides provide a trans-acting splicing enhancer that stimulates SMN2 gene expression in patient fibroblasts | Q34921907 |
| | Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number | Q35250646 |
| | Enhancer 1 binding factor (E1BF), a Ku-related protein, is a growth-regulated RNA polymerase I transcription factor: association of a repressor activity with purified E1BF from serum-deprived cells | Q35762986 |
| | Interferons and IRF-1 induce expression of the survival motor neuron (SMN) genes. | Q35943896 |
| | Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos | Q36578997 |
| | Modulation of survival motor neuron pre-mRNA splicing by inhibition of alternative 3' splice site pairing | Q38296244 |
| | A mouse model for spinal muscular atrophy | Q38316939 |
| | From epinephrine to cyclic AMP. | Q39247573 |
| | Influenza virus infection induces metallothionein gene expression in the mouse liver and lung by overlapping but distinct molecular mechanisms | Q39529176 |
| | Identification and functional characterisation of the cellular activating transcription factor 43 (ATF-43) protein | Q40506507 |
| | Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1. | Q40741164 |
| | Promoter analysis of the human centromeric and telomeric survival motor neuron genes (SMNC and SMNT). | Q40948398 |
| | Correlation between severity and SMN protein level in spinal muscular atrophy | Q41102726 |
| | Both the basic region and the 'leucine zipper' domain of the cyclic AMP response element binding (CREB) protein are essential for transcriptional activation | Q41200854 |
| | The neurobiology of childhood spinal muscular atrophy. | Q41489423 |
| | Transcriptional regulation by cyclic AMP | Q41550266 |
| | Embryonic mouse spinal cord motor neuron hybrid cells | Q41667482 |
| | CREB and memory | Q41733280 |
| | The genetic component in child mortality | Q42041759 |
| | Suppression of metallothionein gene expression in a rat hepatoma because of promoter-specific DNA methylation | Q42481666 |
| | Downregulation of constitutive and heavy metal-induced metallothionein-I expression by nuclear factor I. | Q42507009 |
| | When Is a Deletion Not a Deletion? When It Is Converted | Q43105061 |
| | The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy | Q43569750 |
| | The SMN genes are subject to transcriptional regulation during cellular differentiation | Q43815591 |
| | NMDA receptor-dependent CREB activation in survival of cerebellar granule cells during in vivo and in vitro development | Q44197938 |
| | Correction of disease-associated exon skipping by synthetic exon-specific activators | Q44276105 |
| | The Relationship between SMN, the Spinal Muscular Atrophy Protein, and Nuclear Coiled Bodies in Differentiated Tissues and Cultured Cells | Q57918031 |
| | Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene | Q59084755 |
| | International SMA consortium meeting. (26-28 June 1992, Bonn, Germany) | Q67481178 |
| | Molecular analysis of candidate genes on chromosome 5q13 in autosomal recessive spinal muscular atrophy: evidence of homozygous deletions of the SMN gene in unaffected individuals | Q70987146 |
| | Characterization of a protein that interacts with the rat ribosomal gene promoter and modulates RNA polymerase I transcription | Q72526414 |
| | Modification of the megaprimer method of PCR mutagenesis: improved amplification of the final product | Q72960146 |
| | The survival motor neuron (SMN) protein: effect of exon loss and mutation on protein localization | Q73208213 |
| | An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN | Q73295491 |
| | Homozygous exon 7 deletion of the SMN centromeric gene (SMN2): a potential susceptibility factor for adult-onset lower motor neuron disease | Q78055083 |
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 14803-14811 | |
| P577 | publication date | 2004-01-23 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Identification of a novel cyclic AMP-response element (CRE-II) and the role of CREB-1 in the cAMP-induced expression of the survival motor neuron (SMN) gene | |
| P478 | volume | 279 | |